Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

Contributed by: Business Wire

Logo

Tags

Biotechnology

Health

Clinical Trials

Proposed Public Offering of American Depositary Shar

More Like This

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

Silence Therapeutics Announces Oversubscribed $120 Million Private Placement

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

Silence Therapeutics to Present at Jefferies Global Healthcare Conference

Silence Therapeutics to Participate in September Investor Conferences

Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights